Cardio Diagnostics Holdings EBITDA Margin Growth & History (CDIO)

Cardio Diagnostics Holdings's ebitda margin was −43,297.44% for fiscal 2025.

View full Cardio Diagnostics Holdings company overview

Cardio Diagnostics Holdings annual ebitda margin history

Cardio Diagnostics Holdings annual ebitda margin

Fiscal yearPeriod endedEBITDA marginChange (percentage points)
20252025-12-31−43,297.44%−19376.14 pp
20242024-12-31−23,921.29%+18406.73 pp
20232023-12-31−42,328.02%+434772.08 pp
20222022-12-31−477,100.11%−410013.76 pp
20212021-12-31−67,086.35%

Cardio Diagnostics Holdings ebitda margin trends

Between the periods ended 2021-12-31 and 2025-12-31, Cardio Diagnostics Holdings's ebitda margin increased from −67,086.35% to −43,297.44%, a change of +23788.91 percentage points. The latest reported quarter, Q2 2026, shows −27,846.16%.

About the metric

What EBITDA margin means

EBITDA margin measures EBITDA as a percentage of revenue. It can help compare operating profitability over time, but it excludes capital intensity, financing costs, taxes, and other items and is generally unsuitable for financial companies.

Calculation and source

How EBITDA margin is calculated

TickerStat calculates EBITDA margin as EBITDA divided by positive reported revenue for the same fiscal period. Changes are shown in percentage points. Fiscal periods can differ from calendar years, so exact period-end dates are included.

Review Cardio Diagnostics Holdings source filings ↗

Community posts

It’s quiet here.

No posts about CDIO yet. Start the conversation.

Write the first post